UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31,September 30, 2021
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 000-55019
GENERATION HEMP, INC.
(Exact name of registrant as specified in its charter)
| 26-3119496 | ||
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 8533 Midway Road | ||
| Dallas, Texas | 75209 | |
| (Address of principal executive offices) | (Zip code) |
(469) 209-6154
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock, no par value | GENH | OTC MARKETS |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 12,November 15, 2021, the registrant had 34,977,953111,486,996 shares of common stock outstanding.
TABLE OF CONTENTS
i
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (the “Quarterly Report”) includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical fact included in this report, regarding our strategy, future operations, financial position, estimated revenue, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this Quarterly Report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements described under, but not limited to, the heading “Item 1A. Risk Factors” included in the Annual Report of Generation Hemp, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020 (the “Annual Report”) and our other filings with the Securities and Exchange Commission (“SEC”).
Forward-looking statements may include statements about:
| ● | the risk that our results could be adversely affected by natural disaster, public health crises (including, without limitation, the |
| ● | the marketability of our products; |
| ● | financial condition and liquidity of our customers; |
| ● | competition in the hemp markets; |
| ● | industry and market conditions; |
| ● | requisition of our services by major customers and our ability to renew processing and services contracts; |
| ● | credit and performance risks associated with customers, suppliers, banks and other financial counterparties; |
| ● | availability, timing of delivery and costs of key supplies, capital equipment or commodities; |
| ● | our future capital requirements and our ability to raise additional capital to finance our activities; |
| ● | the future trading of our common stock; |
| ● | legal and regulatory risks associated with OTC Markets; |
| ● | our ability to operate as a public company; |
| ● | our ability to protect our proprietary information; |
| ● | general economic and business conditions; the volatility of our operating results and financial condition; |
| ● | our ability to attract or retain qualified senior management personnel and research and development staff; |
| ● | timing for completion of major acquisitions or capital projects; |
| ● | our ability to obtain additional financing on favorable terms, if required, to complete acquisitions as currently contemplated or to fund the operations and growth of our business; |
| ● | operating or other expenses or changes in the timing thereof; |
| ● | compliance with stringent laws and regulations, as well as changes in the regulatory environment, the adoption of new or revised laws, regulations and permitting requirements, especially with respect to the industry in which we operate; |
| ● | potential legal proceedings and regulatory inquiries against us; and |
| ● | other risks identified in this report that are not historical. |
ii
We caution you that these forward-looking statements are subject to a number of risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control, including risks specific to the industry in which we operate. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved or occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results.
All forward-looking statements, expressed or implied, included in this report are expressly qualified in their entirety by this cautionary statement and speak only as of the date of this Quarterly Report. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue.
Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this report.
ii
iii
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements
Generation Hemp, Inc.
Unaudited Condensed Consolidated Balance Sheets
| September 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash | $ | 134,165 | $ | 2,776,425 | ||||
| Accounts receivable | 127,665 | - | ||||||
| Prepaid expenses | 14,232 | - | ||||||
| Total Current Assets | 276,062 | 2,776,425 | ||||||
| Property and Equipment | ||||||||
| Property and equipment | 3,012,316 | 1,222,430 | ||||||
| Accumulated depreciation | (417,135 | ) | (102,938 | ) | ||||
| Total Property and Equipment, Net | 2,595,181 | 1,119,492 | ||||||
| Operating lease right-of-use asset | 286,839 | - | ||||||
| Intangible assets, net | 2,474,136 | - | ||||||
| Goodwill | 509,701 | |||||||
| Other assets | 407,000 | 23,077 | ||||||
| Total Assets | $ | 6,548,919 | $ | 3,918,994 | ||||
| Liabilities and Equity (Deficit) | ||||||||
| Current Liabilities | ||||||||
| Accounts payable | $ | 1,061,873 | $ | 1,053,542 | ||||
| Accrued liabilities | 375,521 | 337,588 | ||||||
| Payables to related parties | 167,482 | 448,271 | ||||||
| Operating lease liability - related party | 98,749 | - | ||||||
| Notes payable – related parties | 2,360,000 | 3,336,592 | ||||||
| Other indebtedness - current | 516,359 | 619,461 | ||||||
| Common stock issuable | - | 50,000 | ||||||
| Current liabilities of discontinued operations held for sale | 137,068 | 140,068 | ||||||
| Total Current Liabilities | 4,717,052 | 5,985,522 | ||||||
| Operating lease liability - related party, net of current portion | 188,090 | - | ||||||
| Other indebtedness - long-term | - | 25,200 | ||||||
| Long-term liabilities of discontinued operations held for sale | 158,498 | 144,149 | ||||||
| Total Liabilities | 5,063,640 | 6,154,871 | ||||||
| Commitments and Contingencies | ||||||||
| Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 and 135 shares issued and outstanding at September 30, 2021 and December 31, 2020 | 591,558 | 729,058 | ||||||
| Equity (Deficit) | ||||||||
| Series A preferred stock, $0.00001 par value; $1.00 stated value; 6,500,000 shares authorized, none and 6,328,948 shares issued and outstanding at September 30, 2021 and December 31, 2020 | - | 4,975,503 | ||||||
| Common stock, $0.00001 par value; 200,000,000 shares authorized, 111,070,329 shares issued and outstanding at September 30, 2021 | 1,111 | - | ||||||
| Common stock, no par value; 100,000,000 shares authorized, 17,380,317 shares issued and outstanding at December 31, 2020 | - | 6,083,480 | ||||||
| Additional paid-in capital | 23,776,409 | 4,436,018 | ||||||
| Accumulated deficit | (22,644,284 | ) | (18,220,705 | ) | ||||
| Generation Hemp equity | 1,133,236 | (2,725,704 | ) | |||||
| Noncontrolling interest | (239,515 | ) | (239,231 | ) | ||||
| Total Equity (Deficit) | 893,721 | (2,964,935 | ) | |||||
| Total Liabilities and Equity (Deficit) | $ | 6,548,919 | $ | 3,918,994 | ||||
| March 31, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Assets | ||||||||
| Current Assets | ||||||||
| Cash | $ | 1,257,473 | $ | 2,776,425 | ||||
| Accounts receivable | 85,674 | - | ||||||
| Inventories | 700,000 | - | ||||||
| Prepaid expenses | 11,230 | - | ||||||
| Total Current Assets | 2,054,377 | 2,776,425 | ||||||
| Property and Equipment | ||||||||
| Property and equipment, other | 2,934,600 | 1,222,430 | ||||||
| Accumulated depreciation | (207,110 | ) | (102,938 | ) | ||||
| Total Property and Equipment, Net | 2,727,490 | 1,119,492 | ||||||
| Operating lease right-of-use asset | 332,645 | - | ||||||
| Intangible assets, net | 3,088,338 | - | ||||||
| Other assets | 49,650 | 23,077 | ||||||
| Total Assets | $ | 8,252,500 | $ | 3,918,994 | ||||
| Liabilities and Equity (Deficit) | ||||||||
| Current Liabilities | ||||||||
| Accounts payable | $ | 787,788 | $ | 1,053,542 | ||||
| Accrued liabilities | 367,914 | 337,588 | ||||||
| Payables to related parties | 61,383 | 448,271 | ||||||
| Operating lease liability - related party | 93,952 | - | ||||||
| Notes payable – related parties | 1,790,940 | 3,336,592 | ||||||
| Other indebtedness - current | 618,721 | 619,461 | ||||||
| Common stock issuable | - | 50,000 | ||||||
| Current liabilities of discontinued operations held for sale | 136,341 | 140,068 | ||||||
| Total Current Liabilities | 3,857,039 | 5,985,522 | ||||||
| Operating lease liability - related party, net of current portion | 238,693 | - | ||||||
| Other indebtedness - long-term | 25,200 | 25,200 | ||||||
| Long-term liabilities of discontinued operations held for sale | 151,390 | 144,149 | ||||||
| Total Liabilities | 4,272,322 | 6,154,871 | ||||||
| Commitments and Contingencies | ||||||||
| Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 135 shares issued and outstanding | 729,058 | 729,058 | ||||||
| Equity (Deficit) | ||||||||
| Series A preferred stock, no par value; $1.00 stated value; 6,500,000 shares authorized, 6,328,948 shares issued and outstanding | 4,975,503 | 4,975,503 | ||||||
| Common stock, no par value; 100,000,000 shares authorized, 34,977,953 and 17,380,317 shares issued and outstanding at March 31, 2021 and December 31, 2020 | 15,694,375 | 6,083,480 | ||||||
| Common stock warrants | 2,894,642 | 4,436,018 | ||||||
| Accumulated deficit | (20,077,837 | ) | (18,220,705 | ) | ||||
| Generation Hemp equity | 3,486,683 | (2,725,704 | ) | |||||
| Noncontrolling interest | (235,563 | ) | (239,231 | ) | ||||
| Total Equity (Deficit) | 3,251,120 | (2,964,935 | ) | |||||
| Total Liabilities and Equity (Deficit) | $ | 8,252,500 | $ | 3,918,994 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
1
Generation Hemp, Inc.
Unaudited Condensed Consolidated Statements of Operations
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Revenue | ||||||||
| Post-harvest and midstream services | $ | 44,610 | $ | - | ||||
| Rental | 22,500 | 22,500 | ||||||
| Total revenue | 67,110 | 22,500 | ||||||
| Costs and Expenses | ||||||||
| Cost of revenue (exclusive of items shown separately below) | 158,065 | - | ||||||
| Depreciation and amortization | 349,628 | 22,884 | ||||||
| Merger and acquisition costs | 10,766 | 86,011 | ||||||
| General and administrative | 1,126,281 | 569,856 | ||||||
| Total costs and expenses | 1,644,740 | 678,751 | ||||||
| Operating loss | (1,577,630 | ) | (656,251 | ) | ||||
| Other expense (income) | ||||||||
| Interest and other income | - | (1 | ) | |||||
| Change in fair value of marketable security | (11,770 | ) | 23,619 | |||||
| Interest expense | 263,840 | 69,516 | ||||||
| Total other expense | 252,070 | 93,134 | ||||||
| Loss from continuing operations | (1,829,700 | ) | (749,385 | ) | ||||
| (Loss) income from discontinued operations | (3,514 | ) | 6,744 | |||||
| Net loss | $ | (1,833,214 | ) | $ | (742,641 | ) | ||
| Less: net loss (income) attributable to noncontrolling interests | 3,668 | (30,075 | ) | |||||
| Net loss attributable to Generation Hemp | $ | (1,836,882 | ) | $ | (712,566 | ) | ||
| Earnings (loss) per common share: | ||||||||
| Loss from continuing operations | ||||||||
| Basic | $ | (0.07 | ) | $ | (0.04 | ) | ||
| Diluted | $ | (0.07 | ) | $ | (0.04 | ) | ||
| (Loss) income from discontinued operations | ||||||||
| Basic | $ | (0.00 | ) | $ | 0.00 | |||
| Diluted | $ | (0.00 | ) | $ | 0.00 | |||
| Earnings (loss) per share | ||||||||
| Basic | $ | (0.07 | ) | $ | (0.04 | ) | ||
| Diluted | $ | (0.07 | ) | $ | (0.04 | ) | ||
| For the three months ended September 30, | For the nine months ended September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Revenue | ||||||||||||||||
| Post-harvest and midstream services | $ | 487,088 | $ | - | $ | 535,053 | $ | - | ||||||||
| Rental | 15,000 | 22,500 | 60,000 | 67,500 | ||||||||||||
| Total revenue | 502,088 | 22,500 | 595,053 | 67,500 | ||||||||||||
| Costs and Expenses | ||||||||||||||||
| Cost of revenue (exclusive of items shown separately below) | 279,621 | - | 549,881 | - | ||||||||||||
| Depreciation and amortization | 315,729 | 16,038 | 1,006,804 | 54,961 | ||||||||||||
| Merger and acquisition costs | �� | - | 6,856 | 16,115 | 99,880 | |||||||||||
| General and administrative | 1,128,298 | 108,728 | 2,763,529 | 883,565 | ||||||||||||
| Total costs and expenses | 1,723,648 | 131,622 | 4,336,329 | 1,038,406 | ||||||||||||
| Operating loss | (1,221,560 | ) | (109,122 | ) | (3,741,276 | ) | (970,906 | ) | ||||||||
| Other expense (income) | ||||||||||||||||
| Interest and other income | - | - | (25,424 | ) | (1 | ) | ||||||||||
| Change in fair value of marketable security | - | (1,826 | ) | (11,770 | ) | 14,736 | ||||||||||
| Interest expense | 155,505 | 68,475 | 651,807 | 204,875 | ||||||||||||
| Total other expense | 155,505 | 66,649 | 614,613 | 219,610 | ||||||||||||
| Loss from continuing operations | (1,377,065 | ) | (175,771 | ) | (4,355,889 | ) | (1,190,516 | ) | ||||||||
| Loss from discontinued operations | (1,630 | ) | (7,989 | ) | (11,349 | ) | (5,457 | ) | ||||||||
| Net loss | $ | (1,378,695 | ) | $ | (183,760 | ) | $ | (4,367,238 | ) | $ | (1,195,973 | ) | ||||
| Less: net loss attributable to noncontrolling interests | (1,137 | ) | (4,904 | ) | (284 | ) | (44,266 | ) | ||||||||
| Net loss attributable to Generation Hemp | $ | (1,377,558 | ) | $ | (178,856 | ) | $ | (4,366,954 | ) | $ | (1,151,707 | ) | ||||
| Earnings (loss) per common share: | ||||||||||||||||
| Loss from continuing operations | ||||||||||||||||
| Basic | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Diluted | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Loss from discontinued operations | ||||||||||||||||
| Basic | $ | - | $ | - | $ | - | $ | - | ||||||||
| Diluted | $ | - | $ | - | $ | - | $ | - | ||||||||
| Earnings (loss) per share | ||||||||||||||||
| Basic | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Diluted | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
Generation Hemp, Inc.
Unaudited Condensed Consolidated Statements of Equity
| Series B Redeemable Preferred Stock | Series A Preferred Stock | Common Stock | Additional Paid-In | Accumulated | Noncontrolling | Total Equity | ||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Capital | Deficit | Interest | (Deficit) | |||||||||||||||||||||||||||||||
| Balance at January 1, 2020 | - | $ | - | 6,328,948 | $ | 4,975,503 | 17,130,317 | $ | 6,029,328 | $ | 3,426,946 | $ | (16,722,036 | ) | $ | (184,551 | ) | $ | (2,474,810 | ) | ||||||||||||||||||||
| Issuance of common stock units | - | - | - | - | 250,000 | 54,152 | 45,848 | - | - | 100,000 | ||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (712,566 | ) | (30,075 | ) | (742,641 | ) | |||||||||||||||||||||||||||
| Balance at March 31, 2020 | - | - | 6,328,948 | $ | 4,975,503 | 17,380,317 | 6,083,480 | 3,472,794 | (17,434,602 | ) | (214,626 | ) | (3,117,451 | ) | ||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (260,285 | ) | (9,287 | ) | (269,572 | ) | |||||||||||||||||||||||||||
| Balance at June 30, 2020 | - | - | 6,328,948 | $ | 4,975,503 | 17,380,317 | 6,083,480 | 3,472,794 | (17,694,887 | ) | (223,913 | ) | (3,387,023 | ) | ||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (178,856 | ) | (4,904 | ) | (183,760 | ) | |||||||||||||||||||||||||||
| Balance at September 30, 2020 | - | $ | - | 6,328,948 | $ | 4,975,503 | 17,380,317 | $ | 6,083,480 | $ | 3,472,794 | $ | (17,873,743 | ) | $ | (228,817 | ) | $ | (3,570,783 | ) | ||||||||||||||||||||
| Balance at January 1, 2021 | 135 | $ | 729,058 | 6,328,948 | $ | 4,975,503 | 17,380,317 | $ | 6,083,480 | $ | 4,436,018 | $ | (18,220,705 | ) | $ | (239,231 | ) | $ | (2,964,935 | ) | ||||||||||||||||||||
| Acquisition of Certain Assets of Halcyon Thruput, LLC | - | - | - | - | 6,250,000 | 2,500,000 | - | - | - | 2,500,000 | ||||||||||||||||||||||||||||||
| Issuances of common stock units | - | - | - | - | 800,000 | 136,707 | 263,293 | - | - | 400,000 | ||||||||||||||||||||||||||||||
| Warrant exercises | - | - | - | - | 8,428,976 | 4,771,669 | (1,804,669 | ) | - | 2,967,000 | ||||||||||||||||||||||||||||||
| Issuance of common shares for Convertible Promissory Note | - | - | - | - | 618,660 | 217,769 | - | - | - | 217,769 | ||||||||||||||||||||||||||||||
| Issuance of common shares for Senior Secured Promissory Note | - | - | - | - | 1,000,000 | 1,942,500 | - | - | - | 1,942,500 | ||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | 500,000 | 42,250 | - | - | - | 42,250 | ||||||||||||||||||||||||||||||
| Series B preferred stock dividend | - | - | - | - | - | - | - | (20,250 | ) | - | (20,250 | ) | ||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (1,836,882 | ) | 3,668 | (1,833,214 | ) | ||||||||||||||||||||||||||||
| Balance at March 31, 2021 | 135 | 729,058 | 6,328,948 | 4,975,503 | 34,977,953 | 15,694,375 | 2,894,642 | (20,077,837 | ) | (235,563 | ) | 3,251,120 | ||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | - | 38,750 | - | - | - | 38,750 | ||||||||||||||||||||||||||||||
| Series B preferred stock redemption | (17 | ) | (137,500 | ) | - | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||
| Series B preferred stock dividend | - | - | - | - | - | - | - | (20,250 | ) | - | (20,250 | ) | ||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (1,152,514 | ) | (2,815 | ) | (1,155,329 | ) | |||||||||||||||||||||||||||
| Balance at June 30, 2021 | 118 | 591,558 | 6,328,948 | 4,975,503 | 34,977,953 | 15,733,125 | 2,894,642 | (21,250,601 | ) | (238,378 | ) | 2,114,291 | ||||||||||||||||||||||||||||
| Common shares issued to vendor for services | - | - | - | - | 125,000 | 117,500 | - | - | - | 117,500 | ||||||||||||||||||||||||||||||
| Issuance of common shares for extension of secured note | - | - | - | - | 20,000 | 18,000 | - | - | - | 18,000 | ||||||||||||||||||||||||||||||
| Change in common stock par value due to change in corporate domicile | - | - | - | - | - | (15,868,273 | ) | 15,868,273 | - | - | - | |||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | - | - | 38,750 | - | - | 38,750 | ||||||||||||||||||||||||||||||
| Conversion of Series A preferred stock | (6,328,948 | ) | (4,975,503 | ) | 75,947,376 | 759 | 4,974,744 | - | - | - | ||||||||||||||||||||||||||||||
| Series B preferred stock dividend | - | - | - | - | - | - | - | (16,125 | ) | - | (16,125 | ) | ||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (1,377,558 | ) | (1,137 | ) | (1,378,695 | ) | |||||||||||||||||||||||||||
| Balance at September 30, 2021 | 118 | $ | 591,558 | - | $ | - | 111,070,329 | $ | 1,111 | $ | 23,776,409 | $ | (22,644,284 | ) | $ | (239,515 | ) | $ | 893,721 | |||||||||||||||||||||
| Series B Redeemable Preferred Stock | Series A Preferred Stock | Common Stock | Common Stock | Accumulated | Noncontrolling | Total | ||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | Shares | Amount | Warrants | Deficit | Interest | Equity (Deficit) | |||||||||||||||||||||||||||||||
| Balance at January 1, 2020 | - | $ | - | 6,328,948 | $ | 4,975,503 | 17,130,317 | $ | 6,029,328 | $ | 3,426,946 | $ | (16,722,036 | ) | $ | (184,551 | ) | $ | (2,474,810 | ) | ||||||||||||||||||||
| Issuance of common stock units | - | - | - | - | 250,000 | 54,152 | 45,848 | - | - | 100,000 | ||||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (712,566 | ) | (30,075 | ) | (742,641 | ) | |||||||||||||||||||||||||||
| Balance at March 31, 2020 | - | $ | - | 6,328,948 | $ | 4,975,503 | 17,380,317 | $ | 6,083,480 | $ | 3,472,794 | $ | (17,434,602 | ) | $ | (214,626 | ) | $ | (3,117,451 | ) | ||||||||||||||||||||
| Balance at January 1, 2021 | 135 | $ | 729,058 | 6,328,948 | $ | 4,975,503 | 17,380,317 | $ | 6,083,480 | $ | 4,436,018 | $ | (18,220,705 | ) | $ | (239,231 | ) | $ | (2,964,935 | ) | ||||||||||||||||||||
| Acquisition of Certain Assets of Halcyon Thruput, LLC | - | - | - | - | 6,250,000 | 2,500,000 | - | - | - | 2,500,000 | ||||||||||||||||||||||||||||||
| Issuances of common stock units | - | - | - | - | 800,000 | 136,707 | 263,293 | - | - | 400,000 | ||||||||||||||||||||||||||||||
| Warrant exercises | - | - | - | - | 8,428,976 | 4,771,669 | (1,804,669 | ) | - | 2,967,000 | ||||||||||||||||||||||||||||||
| Issuance of common shares for Convertible Promissory Note | - | - | - | - | 618,660 | 217,769 | - | - | - | 217,769 | ||||||||||||||||||||||||||||||
| Issuance of common shares for Senior Secured Promissory Note | - | - | - | - | 1,000,000 | 1,942,500 | - | - | - | 1,942,500 | ||||||||||||||||||||||||||||||
| Stock-based compensation | - | - | - | - | 500,000 | 42,250 | - | - | - | 42,250 | ||||||||||||||||||||||||||||||
| Series B preferred stock dividend | - | - | - | - | - | - | - | (20,250 | ) | - | (20,250 | ) | ||||||||||||||||||||||||||||
| Net loss | - | - | - | - | - | - | - | (1,836,882 | ) | 3,668 | (1,833,214 | ) | ||||||||||||||||||||||||||||
| Balance at March 31, 2021 | 135 | $ | 729,058 | 6,328,948 | $ | 4,975,503 | 34,977,953 | $ | 15,694,375 | $ | 2,894,642 | $ | (20,077,837 | ) | $ | (235,563 | ) | $ | 3,251,120 | |||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Generation Hemp, Inc.
Unaudited Condensed Consolidated Statements of Cash Flows
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Cash Flows From Operating Activities | ||||||||
| Net loss | $ | (1,833,214 | ) | $ | (742,641 | ) | ||
| Loss from discontinued operations | (3,514 | ) | 6,744 | |||||
| Net loss from continuing operations | (1,829,700 | ) | (749,385 | ) | ||||
| Adjustments to reconcile net loss from continuing operations to net cash from operating activities: | ||||||||
| Depreciation expense | 349,628 | 22,884 | ||||||
| Amortization of debt discount | 163,222 | - | ||||||
| Stock-based compensation | 42,250 | - | ||||||
| Loss on disposal of property and equipment | - | 539 | ||||||
| Change in fair value of marketable securities | (11,770 | ) | 23,619 | |||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses and other assets | (21,434 | ) | - | |||||
| Accounts payable and accrued liabilities | (191,171 | ) | 337,360 | |||||
| Net cash from operating activities – continuing operations | (1,498,975 | ) | (364,983 | ) | ||||
| Net cash from operating activities – discontinued operations | - | 31,716 | ||||||
| Net cash from operating activities | (1,498,975 | ) | (333,267 | ) | ||||
| Cash Flows From Investing Activities | ||||||||
| Acquisition of Certain Assets of Halcyon Thruput, LLC, net of acquired cash of $224,530 | (1,525,470 | ) | - | |||||
| Proceeds from sale of investment in common stock | 34,847 | - | ||||||
| Net cash from investing activities – continuing operations | (1,490,623 | ) | - | |||||
| Net cash from investing activities – discontinued operations | - | - | ||||||
| Net cash from investing activities | (1,490,623 | ) | - | |||||
| Cash Flows From Financing Activities | ||||||||
| Proceeds for common stock issuable | - | 50,000 | ||||||
| Issuance of common stock units | 350,000 | 100,000 | ||||||
| Proceeds from warrant exercises | 2,967,000 | - | ||||||
| Repayment of Halcyon bank note | (995,614 | ) | - | |||||
| Proceeds (repayment) of subordinated notes | (850,000 | ) | 150,000 | |||||
| Payment of mortgage payable | (740 | ) | (1,787 | ) | ||||
| Net cash from financing activities – continuing operations | 1,470,646 | 298,213 | ||||||
| Net cash from financing activities – discontinued operations | - | - | ||||||
| Net cash from financing activities | 1,470,646 | 298,213 | ||||||
| Net change in cash | (1,518,952 | ) | (35,054 | ) | ||||
| Cash, beginning of period | 2,776,425 | 101,337 | ||||||
| Cash, end of period | $ | 1,257,473 | $ | 66,283 | ||||
| For the nine months ended September 30, | ||||||||
| 2021 | 2020 | |||||||
| Cash Flows From Operating Activities | ||||||||
| Net loss | $ | (4,367,238 | ) | $ | (1,195,973 | ) | ||
| Loss from discontinued operations | (11,349 | ) | (5,457 | ) | ||||
| Net loss from continuing operations | (4,355,889 | ) | (1,190,516 | ) | ||||
| Adjustments to reconcile net loss from continuing operations to net cash from operating activities: | ||||||||
| Depreciation expense | 1,006,804 | 54,961 | ||||||
| Amortization of debt discount | 380,282 | - | ||||||
| Stock-based compensation | 119,750 | - | ||||||
| Common shares issued to vendor for services | 117,500 | - | ||||||
| Other income - PPP Loan forgiveness | (25,424 | ) | - | |||||
| Loss on disposal of property and equipment | - | 539 | ||||||
| Change in fair value of marketable securities | (11,770 | ) | 14,736 | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (52,195 | ) | - | |||||
| Prepaid expenses | (14,232 | ) | - | |||||
| Accounts payable and accrued liabilities | 176,969 | 466,533 | ||||||
| Net cash from operating activities – continuing operations | (2,658,205 | ) | (653,747 | ) | ||||
| Net cash from operating activities – discontinued operations | - | 31,716 | ||||||
| Net cash from operating activities | (2,658,205 | ) | (622,031 | ) | ||||
| Cash Flows From Investing Activities | ||||||||
| Capital expenditures | (77,716 | ) | - | |||||
| Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530 | (1,525,470 | ) | - | |||||
| Proceeds from sale of investment in common stock | 34,847 | - | ||||||
| Net cash from investing activities – continuing operations | (1,568,339 | ) | - | |||||
| Net cash from investing activities – discontinued operations | - | - | ||||||
| Net cash from investing activities | (1,568,339 | ) | - | |||||
| Cash Flows From Financing Activities | ||||||||
| Proceeds for common stock issuable | - | 150,000 | ||||||
| Issuance of common stock units | 350,000 | 100,000 | ||||||
| Redemptions of Series B preferred stock | (137,500 | ) | - | |||||
| Series B preferred stock dividends paid | (16,500 | ) | - | |||||
| Proceeds from warrant exercises | 2,967,000 | - | ||||||
| Repayment of Halcyon bank note | (995,614 | ) | - | |||||
| Proceeds from SBA PPP Loan | - | 25,200 | ||||||
| Proceeds from subordinated notes | 620,000 | 340,000 | ||||||
| Repayment of subordinated notes | (1,100,000 | ) | - | |||||
| Payment of mortgage payable | (103,102 | ) | (11,740 | ) | ||||
| Net cash from financing activities – continuing operations | 1,584,284 | 603,460 | ||||||
| Net cash from financing activities – discontinued operations | - | - | ||||||
| Net cash from financing activities | 1,584,284 | 603,460 | ||||||
| Net change in cash | (2,642,260 | ) | (18,571 | ) | ||||
| Cash, beginning of period | 2,776,425 | 101,337 | ||||||
| Cash, end of period | $ | 134,165 | $ | 82,766 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Generation Hemp, Inc.
Notes to Unaudited Condensed Consolidated Financial Statements
1. Business
Generation Hemp, Inc. (the “Company”), formerly known as Home Treasure Finders, Inc. (“HTF”), was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger (the “Transaction”). Upon closing of the Transaction, HTF changed its name to Generation Hemp, Inc.
On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. TheIn August 2021, the Company plans to significantly expandlaunched its business lines to include post-processing of biomass for use in a number of new products. This expansion requires certain new equipment to be procured.small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations.
We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to aan unaffiliated hemp seed company.
As of March 31,September 30, 2021, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.
Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain.
Liquidity – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its new strategy and execute its acquisition plans.
In the nine months ended September 30, 2021, the Company used $2.7 million of cash for its operating activities. At September 30, 2021, the Company’s current liabilities, including financing obligations due within one year, totaled $4.7 million as compared with its current assets of $276 thousand. Cash payments under several financing obligations were initially due in September and October of 2021. As disclosed in Notes 5 and 6 below, these were subsequently amended to extend these payments by one to six months.
We are focused on executing our operating strategy now that the Halcyon acquisition has been completed. Management expects to renew contracts with new and existing Halcyon customers for the 2021 harvest. Expansion of our business lines is also expected to result in significant growth in revenues.
The Company will continue to pursue additional fundingcapital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Impact of COVID-19 Pandemic on Our Business – Our business, results of operations and financial condition have been adversely affected by the COVID-19 pandemic, beginning in mid-March 2020. The COVID-19 pandemic and measures taken to contain it have subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.
2. Summary of Significant Accounting Policies
Basis of Presentation – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2020.
In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.
5
Revenue Recognition – Post-harvest and midstream services revenue is typically determined based on volumes processed at agreed-upon contractual prices and is recognized when performance obligations under the terms of a contract with our customers are satisfied. This occurs when control of the product is transferred to our customers upon completion of our processing.
Rental revenue is recognized based on the contractual cash rental payments for the period. Oil & gas revenue is recognized for discontinued operations based on delivered qualitiesquantities in the amount of the consideration to which the Company is entitled.
Stock-based Compensation – We account for employee stock-based compensation using the fair value method. Compensation cost for equity incentive awards is based on the fair value of the equity instrument generally on the date of grant and is recognized over the requisite service period. Forfeitures are recognized as they occur.
Fair Value Measurement – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and notes payable. The fair values of these instruments approximate their carrying amounts at each reporting date.
The Company’s non-financial assets measured at fair value on non-recurring basis include impairment measurements of oil and gas properties and warrants issued as part of financing transactions. These are considered Level 3 measurements as they involve significant unobservable inputs.
Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of March 31,September 30, 2021 or December 31, 2020.
During the three and nine months ended March 31,September 30, 2021, one customer accounted for approximately 96%99% and 90% of our post-harvest and midstream services revenue. The total balance duerevenue, respectively. Amounts outstanding from this customer at March 31, 2021 was approximately 41%represented 99% of total accounts receivable.receivable at September 30, 2021.
Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at March 31,September 30, 2021 or December 31, 2020.
Recent Accounting Pronouncements – NoIn August 2020, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2020-06, Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. ASU 2020-06 simplifies the accounting for convertible instruments by reducing the number of accounting models for convertible debt instruments and convertible preferred stock. Limiting the accounting models results in fewer embedded conversion features being separately recognized from the host contract as compared with current GAAP. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting and (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. ASU 2020-06 also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. The Company elected to early adopt ASU 2020-06 in 2021. Adoption of this new guidance had no impact on its financial statements at the date of adoption but is applicable to newly issued instruments.
There are no other new accounting pronouncements had orthat are expected to have a material impact on the consolidated financial statements.
Reclassifications – Financial statements presented for prior periods include reclassifications that were made to conform to the current-year presentation.
3. Acquisition
On January 11, 2021, the Company completed the acquisition of certain assets of Halcyon pursuant to the Asset Purchase Agreement dated March 7, 2020, as amended on January 11, 2021. The purchase consideration totaled approximately $6.1 million consisting of 6,250,000 shares of Company common stock valued at $2.5 million (valued at $0.40 per share; restricted from trading for a period of up to one year), $1.75 million in cash, a promissory note for $850,000 issued by the Company’s subsidiary, GenH Halcyon Acquisition, LLC, and guaranteed by Gary C. Evans, CEO of the Company, and assumption of approximately $1.0 million of new indebtedness of Halcyon. The Company was granted an option to purchase the real estate occupied by Halcyon for $993,000. This option is exercisable at any time before its expiration on January 11, 2022.
The acquisition was accounted for as a business combination where the Company is the acquirer and the acquisition method of accounting was applied in accordance with GAAP. Accordingly, the aggregate value of the consideration we paid to complete the acquisition was allocated to the assets acquired based upon their estimated fair values on the acquisition date.
6
The following table summarizes the purchase price allocation tofor the assets acquired. This allocation is preliminary. In the third quarter of 2021, we made adjustments to the previously recognized amounts for inventory, intangibles, goodwill and the real estate purchase option based on the preliminary results of a valuation study. The final allocation of the purchase price will be determined at a later date and is dependent on a number of factors, including the final evaluation of the fair value of tangible and identifiable intangible assets acquired. Final adjustments, including increases and decreases to depreciation and amortization resulting from the allocation of the purchase price to amortizable tangible and intangible assets, may be material.
| Accounts receivable | $ | 75,470 | ||
| Inventories | 700,000 | |||
| Other working capital | 224,530 | |||
| Property and equipment, other | 1,712,170 | |||
| Intangibles - customer contracts and lists | 3,333,794 | |||
| Other assets - Purchase option on real estate | 49,650 | |||
| Assets acquired | $ | 6,095,614 |
| Accounts receivable | $ | 75,470 | ||
| Other working capital | 224,530 | |||
| Property and equipment, other | 1,712,170 | |||
| Intangibles: | ||||
| Non-competition agreements | 64,691 | |||
| Customer relationships | 3,102,052 | |||
| Other assets - Purchase option on real estate | 407,000 | |||
| Goodwill | 509,701 | |||
| Assets acquired | $ | 6,095,614 |
Intangible assets consist of customer contractsrelationships and lists and havenon-compete agreements, each having definite-lives. These intangible assets are being amortized over the estimated useful life on an accelerated basis reflecting the anticipated future cash flows of the Company post acquisition of Halcyon.
The results of operations for the acquired Halcyon assets have been included in the Company’s consolidated financial statements since the January 11, 2021 acquisition date.
Concurrent with the closing of the asset acquisition, the Company entered into term employment agreements with two executives to serve as vice presidents of the Company for a term of at least two years. The term employment agreements each provide for the issuance of 250,000 shares of restricted common stock of the Company as a signing bonus. Such shares are subject to restrictions on the trading or transfer of such common stock.
Further, the term employment agreements each provide for the payment by the executives of liquidated damages if the employee terminates his employment without good reason during the initial term, other than due to the employee’s death or disability. Such liquidated damages total $600,000 if such termination occurs on or prior to January 11, 2022 or $375,000 if such termination occurs after January 11, 2022 and prior to January 11, 2023.
On March 3, 2021, the Company repaid the outstanding principal and interest balance on the $850,000 promissory note issued in connection with the acquisition.
Supplemental Pro Forma Information – The supplemental pro forma financial information presented below is for illustrative purposes only and is not necessarily indicative of the financial position or results of operations that would have been realized if the acquisition of certain assets of Halcyon had been completed on the date indicated, nor is it indicative of future operating results or financial position. The pro forma adjustments are based upon currently available information and certain assumptions that management believes are reasonable under the circumstances.
The supplemental pro forma financial information reflects pro forma adjustments to present the combined pro forma results of operations as if the acquisition had occurred on January 1, 2020, to give effect to certain events that management believes to be directly attributable to the acquisition. These pro forma adjustments primarily include:
| ● | an increase to depreciation and amortization expense that would have been recognized due to acquired tangible and intangible assets; and |
| ● | an adjustment to interest expense to reflect the reduced borrowings due to the repayment of Halcyon’s historical debt in conjunction with the acquisition; |
The supplemental pro forma financial information for the periods presented is as follows:
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Revenue, continuing operations | $ | 68,348 | $ | 29,926 | ||||
| Loss from continuing operations | (1,898,597 | ) | (1,162,768 | ) | ||||
| Earnings (loss) per common share: | ||||||||
| Basic and diluted | $ | (0.07 | ) | $ | (0.07 | ) | ||
7
| For the three months ended September 30, | For the nine months ended September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Revenue, continuing operations | $ | 502,088 | $ | 974,434 | $ | 596,291 | $ | 1,106,440 | ||||||||
| Income (loss) from continuing operations | (1,377,065 | ) | 59,631 | (4,424,786 | ) | (1,528,788 | ) | |||||||||
| Earnings (loss) per common share: | ||||||||||||||||
| Basic and diluted | $ | (0.03 | ) | $ | 0.00 | $ | (0.11 | ) | $ | (0.09 | ) | |||||
4. Discontinued Operations
In connection with the Transaction, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.
The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:
| March 31, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Assets - | ||||||||
| Oil and Natural Gas Properties held for sale, at cost, using the successful efforts method | $ | 1,874,849 | $ | 1,874,849 | ||||
| Accumulated DD&A | (1,874,849 | ) | (1,874,849 | ) | ||||
| Total assets of discontinued operations held for sale | $ | - | $ | - | ||||
| Liabilities | ||||||||
| Accrued liabilities | $ | 31,856 | $ | 31,117 | ||||
| Asset retirement obligations | 52,368 | 56,834 | ||||||
| Revenue payable | 52,117 | 52,117 | ||||||
| Note payable | - | - | ||||||
| Current liabilities of discontinued operations held for sale | 136,341 | 140,068 | ||||||
| Asset retirement obligations - | ||||||||
| Long-term liabilities of discontinued operations held for sale | 151,390 | 144,149 | ||||||
| Total liabilities of discontinued operations held for sale | $ | 287,731 | $ | 284,217 | ||||
| September 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Assets - | ||||||||
| Oil and natural gas properties held for sale, at cost | $ | 1,874,849 | $ | 1,874,849 | ||||
| Accumulated DD&A | (1,874,849 | ) | (1,874,849 | ) | ||||
| Total assets of discontinued operations held for sale | $ | - | $ | - | ||||
| Liabilities | ||||||||
| Accrued liabilities | $ | 32,583 | $ | 31,117 | ||||
| Asset retirement obligations | 52,368 | 56,834 | ||||||
| Revenue payable | 52,117 | 52,117 | ||||||
| Current liabilities of discontinued operations held for sale | 137,068 | 140,068 | ||||||
| Asset retirement obligations - | ||||||||
| Long-term liabilities of discontinued operations held for sale | 158,498 | 144,149 | ||||||
| Total liabilities of discontinued operations held for sale | $ | 295,566 | $ | 284,217 | ||||
The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Revenue - | ||||||||
| Oil and gas sales | $ | 21,989 | $ | 71,108 | ||||
| Costs and Expenses | ||||||||
| Lease operating expense | 22,728 | 38,304 | ||||||
| Depreciation, depletion & amortization | - | 8,014 | ||||||
| Accretion | 2,775 | 4,296 | ||||||
| Total costs and expenses | 25,503 | 50,614 | ||||||
| Interest expense | - | 13,750 | ||||||
| Income from discontinued operations | $ | (3,514 | ) | $ | 6,744 | |||
| For the three months ended September 30, | For the nine months ended September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Revenue - | ||||||||||||||||
| Oil and gas sales | $ | 55,140 | $ | 13,036 | $ | 93,248 | $ | 93,361 | ||||||||
| Costs and Expenses | ||||||||||||||||
| Lease operating expense | 53,919 | 16,762 | 94,714 | 77,099 | ||||||||||||
| Depreciation, depletion & amortization | - | - | - | 9,942 | ||||||||||||
| Accretion | 2,851 | 4,263 | 9,883 | 12,868 | ||||||||||||
| Gain on disposal of oil & gas property interests | - | - | (24,008 | ) | ||||||||||||
| Total costs and expenses | 56,770 | 21,025 | 104,597 | 75,901 | ||||||||||||
| Interest expense | - | - | - | 22,917 | ||||||||||||
| Loss from discontinued operations | $ | (1,630 | ) | $ | (7,989 | ) | $ | (11,349 | ) | $ | (5,457 | ) | ||||
8
5. Notes Payable – Related Parties
Notes payable – related parties consisted of the following:
| March 31, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Senior Secured Promissory Note | $ | - | $ | 1,500,000 | ||||
| Convertible Promissory Note | - | 208,874 | ||||||
| Subordinated Promissory Note to CEO | 490,000 | 490,000 | ||||||
| Secured Promissory Note to Coventry Asset Management, LTD. | 1,000,000 | 1,000,000 | ||||||
| Subordinated Promissory Note to Investor | 500,000 | 500,000 | ||||||
| Total | 1,990,000 | 3,698,874 | ||||||
| Less debt discounts | (199,060 | ) | (362,282 | ) | ||||
| Total Notes Payable – Related Parties | $ | 1,790,940 | $ | 3,336,592 | ||||
| September 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Senior Secured Promissory Note | $ | - | $ | 1,500,000 | ||||
| Convertible Promissory Note | - | 208,874 | ||||||
| Subordinated Promissory Note to CEO | 490,000 | 490,000 | ||||||
| Convertible Promissory Note to CEO | 620,000 | - | ||||||
| Secured Promissory Note to Coventry Asset Management, LTD. | 1,000,000 | 1,000,000 | ||||||
| Subordinated Promissory Note to Investor | 250,000 | 500,000 | ||||||
| Total | 2,360,000 | 3,698,874 | ||||||
| Less debt discounts | - | (362,282 | ) | |||||
| Total Notes Payable – Related Parties | $ | 2,360,000 | $ | 3,336,592 | ||||
Senior Secured Promissory Note – On March 9, 2021, the total principal, interest and accrued fees under the Senior Secured Promissory Note was contributed to the Company and exchanged into 1,000,000 common shares.
Convertible Promissory Note – On March 9, 2021, the convertible promissory note issued in October 2019, together with accrued interest thereon, was converted into 618,660 common shares under the terms of the note.
Subordinated Promissory Note to CEO – Our CEO made advances to the Company during 2020 under a subordinated promissory note due September 30, 2021. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $3,735$28,508 at March 31,September 30, 2021 and $22,393 at December 31, 2020. This note was amended to a new maturity date of January 31, 2022.
Convertible Promissory Note to CEO – In the third quarter of 2021, our CEO made advances totaling $620,000 to the Company under a convertible promissory note. The convertible note matures on January 1, 2022, bears interest at 10%. The principal and interest due on the convertible note may be converted, at the option of the holder, into restricted shares of the Company’s common stock at a conversion price equal to $0.50 per share. Accrued interest on this subordinated promissory note totaled $5,047 at September 30, 2021.
Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1,000,000 to Coventry Asset Management, LTD. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 10% per annum. The secured promissory noteannum and accrued interest are dueinitially matured on June 30, 2021. Effective June 30, 2021, the promissory note was extended to a new maturity date of December 31, 2021. The Company agreed to issue 20,000 restricted common shares as a first extension fee, make a payment of $50,000 of accrued interest and a principal payment of $250,000 on October 1, 2021. The accrued interest and principal payment were not made but were subsequently amended. As amended in November 2021, the promissory note’s required payments and maturity date were extended to January 31, 2022. If before December 31, 2021 the Company raises new equity capital of $10 million or more, then the full amount outstanding under the promissory note is due within five days. Additionally, the holder of the promissory note was given an option exercisable in November 2021 to convert $250,000 of the outstanding principal balance into shares of the Company’s common stock at an exercise price of $0.60 per share. The Company agreed to issue 20,000 restricted common shares as a second extension fee. Accrued interest on this secured by the real property acquired in the acquisition of certain assets of Halcyon.note totaled $75,069 at September 30, 2021.
In addition, theThe holder of the secured promissory note received a warrant to purchase 1,000,000 shares of common stock exercisable at an exercise price of $0.352 per share.share upon origination of the promissory note in 2020. This warrant was subsequently exercised in the first quarter of 2021.
Subordinated Promissory Note and Warrants to Investor – On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500,000 to an accredited investor. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The subordinated note and accrued and unpaid interest are due September 30, 2021. The Company made a principal payment of $250,000 in April 2021. The subordinated note principal together with accrued and unpaid interest was due September 30, 2021 but was subsequently extended. As amended, payments of $125,000 each are due on January 31, 2022 and March 31, 2022 together with accrued interest thereon. If at any time prior to the note’s maturity the Company raises new equity capital of $12.5 million or more, then the full amount outstanding under the note is due within five days. Accrued interest on this subordinated promissory note totaled $12,466$18,733 at March 31, 2021.
If at any time prior to September 30, 2021, the Company raises new equity capital in the amount of $5,000,000 or more, then within five business days of closing, repayment of all outstanding principal and interest on the Subordinated Note will be due.2021.
In addition, theThe holder of the subordinated note received a warrant to purchase 500,000 shares of common stock exercisable until December 30, 2022 at an exercise price of $0.352 per share.
9
6. Other Indebtedness
Other indebtedness consisted of the following:
| March 31, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Mortgage Payable | $ | 618,721 | $ | 619,461 | ||||
| Paycheck Protection Program Loan | 25,200 | 25,200 | ||||||
| Total | 643,921 | 644,661 | ||||||
| Less current portion | (618,721 | ) | (619,461 | ) | ||||
| Total Other Indebtedness - Long-Term | $ | 25,200 | $ | 25,200 | ||||
| September 30, | December 31, | |||||||
| 2021 | 2020 | |||||||
| Mortgage Payable | $ | 516,359 | $ | 619,461 | ||||
| Paycheck Protection Program Loan | - | 25,200 | ||||||
| Total | 516,359 | 644,661 | ||||||
| Less current portion | (516,359 | ) | (619,461 | ) | ||||
| Total Other Indebtedness - Long-Term | $ | - | $ | 25,200 | ||||
Mortgage Payable and Operating Lease—The Company is obligated under a mortgage payable, dated September 15, 2014 and as amended October 1, 2019, secured by its warehouse property located in Denver, Colorado. The note providesprovided for a 25-year amortization period and an initial interest rate of 9% annually. As amended, the note matured on January 15, 2021 but was extended under terms of the amendment to July 15, 2021 after payment by the Company of an extension fee of 1% of the then outstanding principal. The rate during this extension period was 11% annually.
In July 2021, the mortgage payable was amended to a new maturity date of October 15, 2021. The Company made a $100,000 principal payment and paid an extension fee of $6,000 in July 2021 for this amendment. The rate during the extension period is 11%was increased to 12% annually and the new monthly payment is $6,067.$5,279.
In October 2021, the mortgage payable was amended to a new maturity date of January 15, 2022. The Company will pay an extension fee of $1,000 each month beginning November 15, 2021. The new monthly payment of the note is $5,500 including interest at an effective rate of approximately 13%.
The Company leases the Denver warehouse property to a tenant under an operating lease expiring June 30, 2021which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7,500. The lease requires a true-up with the tenant reimburse us for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for the remainder of 2021 are $22,500.$22,500, for 2022 are $90,000 and for 2023 are $52,500.
Paycheck Protection Program Loan – Congress created the Paycheck Protection Program (“PPP”) under the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to provide forgivable loans to eligible small businesses facing economic hardship to retain U.S. employees on their payroll during the Coronavirus Disease 2019 (“COVID-19”) pandemic.
PPP loan recipients may be eligible to have their loans forgiven if the funds were used for eligible expenses over the eight-week coverage period commencing when the loan was originally disbursed. The amount of forgiveness may be reduced if the percentage of eligible expenses attributed to nonpayroll expenses exceeds 25% of the loan, if employee headcount decreases, or compensation decreases by more than 25% for each employee making less than $100,000 per year, unless the reduced headcount or compensation levels are restored.
On April 29, 2020, Generation Hemp, Inc.we received disbursement of an approved PPP loan in the amount of $25,200. The Company received notice from the SBA that the PPP Loan principal and interest thereon was fully forgiven on April 20, 2021.
7. Commitments and Contingencies
Leases – The Company assumed Halcyon’s lease of office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2,000 and is month-to-month. Lease expense for this facility totaled $4,000$6,000 and $16,000 in the three and nine months ended March 31, 2021.September 30, 2021, respectively.
The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10,249. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $27,110$30,747 and $88,604 in the three and nine months ended March 31, 2021.September 30, 2021, respectively. A right-of-use asset and lease liability is recorded for this lease.
The right-of-use asset represent the right to use the underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. A right-of-use asset and lease liabilities were recognized at the commencement date based on the present value of lease payments over the lease term. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.
Pending Insurance Claim – In 2019, drying equipment that Halcyon purchased from a third party was being placed into service when a fire loss subsequently occurred and destroyed the equipment causing significant business interruption. The cost of this drying equipment totaled $1.1 million. In 2020, Halcyon received, as partial payment, insurance proceeds of $595,000 from its insurance carrier.
In the acquisition of Halcyon, the Company assumed Halcyon’s rights to any future recoveries related to the fire loss. The Company has filed for additional claims of in excess of $1.0 millionmade a formal claim against Halcyon’sthe insurance carrier including violation of Prompt Payment of Claims Act and Texas Insurance Code violations. The Company may also pursue additional recovery of its losses againstis pursuing all available options to recover the third-party general contractor and its insurers. No amounts have been recognized for the possible recovery of these losses.unpaid amounts.
10
Litigation – From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot predict the ultimate outcome of these matters.
JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723
JDONE, LLC (“JDONE”) is a wholly owned subsidiary of the Company and landlord of a commercial warehouse building that was leased to Grand Traverse Holdings, LLC on December 31, 2018 for a term of 61 months, with a personal guaranty from Defendant, John Gallegos. On April 12, 2019, Grand Traverse presented JDONE with an alleged forged, signed copy of the draft early termination amendment that JDONE had previously rejected. JDONE has suffered damages due to Defendant’s alleged misconduct of approximately $823,504 plus interest and attorney’s fees.fees exceeding $300,000. A court ordered mediation was held in May 2020 without success. All material defendant motions have been denied by the court. The case is set for jury trial in June 2021.January 2022. We believe that Grand Traverse Holdings, LLC and John Gallegos are jointly liable for the asserted damages which exceed $1 million and continue to vigorously pursue our claims.
KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII”) vs. Energy Hunter Resources, Inc.
Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR has filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $230,712. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At March 31,September 30, 2021, the Company had accrued $252,583 for this judgment.judgment, which is exclusively an EHR obligation.
Arbitration – Jones & Keller, P.C.
In February 2021, Jones & Keller, P.C., a Denver law firm that previously represented the Company, filed an arbitration demand against the Company and JDONE for the payment of alleged legal fees owing regarding our lawsuit against Grand Traverse Holdings, LLC and John Gallegos discussed above. We subsequently engaged new legal counsel and filed a counterclaim for charging inappropriate and unreasonable legal fees and for unreasonable, unnecessary and duplicative work. An arbitration hearing is anticipated during the summer of 2021.
8. Equity
Change of Corporate Domicile – On August 21, 2021, the Company changed its domicile from the State of Colorado to the State of Delaware. The change of domicile had no effect on the number of outstanding securities of the Company. The Company is authorized for 200 million shares of capital stock, par value $0.00001 per share and 20 million shares of preferred stock, par value $0.00001 per share.
Series A Preferred Stock – The Company hasOn September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred outstanding. EachStock were converted into 75,947,376 shares of common stock, with each share of the Series A Preferred; (a) convertsPreferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of the Company, (b) possesses full voting rights, on an as-converted basis,Designations. The Series A Preferred Stock was originally issued in connection with the common stock of the Company, and (c) has no dividend rate.Company’s merger transaction completed in December 2019.
December 2020 Issuance of Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company.Company until December 30, 2022 at an exercise price of $0.352 per share.
The sale of the preferred stock units for $10,000 each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.
Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10,000 per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.
Beginning the later of June 30, 2021 or the effectiveness of any registration statement registering the underlying common shares, all or any portion of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.
11
At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5,000,000 at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.
The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. On June 30, 2021, September 30, 2021 and December 31, 2021,Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends will bewere due from the Company to each Holder of Series B Preferred Stock.Stock at the end of each calendar quarter of 2021. The first required redemption payment waspayments totaling $137,500 were made in April 2021.
Each warrant is exercisable until December 30, 2022 at an exercise priceIn May, June and October of $0.352 per share.2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.
Common Stock – At March 31,September 30, 2021, the Company had 34,977,953111,070,329 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:
| ● | February 2020 Issuance of Common Stock Units – In February 2020, the Company issued 250,000 common units for $100,000. Each unit consisted of one share of common stock and a warrant for purchase of one common share for $0.40 per share. The warrant expires March 1, 2022 and |
The common stock issued in the exchange was valued using the trading price of the common stock on February 20, 2020. The warrants were valued at $45,848 using a binomial lattice valuation model using inputs as of the exchange date. Our expected volatility assumption was based on the historical volatility of the Company’s common stock (252%). The expected life assumption was based on the expiration date of the warrant (two years). The risk-free interest rate for the expected term of the warrant was based on the U.S. Treasury yield curve in effect at the time of measurement (1.39%). The warrants are classified within equity in the consolidated balance sheets. Under GAAP, the anti-dilution provisions will be accounted for if and when these provisions are triggered.
| ● | Acquisition of Certain Assets of Halcyon– the Company issued 6,250,000 shares of common stock valued at $2.5 million (valued at $0.40 per share; restricted from trading for a period of up to one year) in the acquisition. Refer to Note 3. |
| ● | 2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital. |
| ● | Warrant Exercises – In the first quarter of 2021, the Company received $2,967,000 |
| ● | Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt. Refer to Note 5. |
| ● | Issuance to Vendor for Services – In the third quarter of 2021, the Company issued 125,000 common shares to a vendor for services performed. |
| ● | Issuance for Extension of Secured Note – The Company issued 20,000 common shares as consideration to extend the maturity of a senior note in the third quarter of 2021. Refer to Note 5. |
| ● | Issuance for Conversion of Series A Preferred Stock – As noted above, in the third quarter of 2021, the Company issued 75,947,376 common shares for the conversion of all outstanding shares of its Series A Preferred Stock. |
| ● | Stock-based Compensation – The Company issued 500,000 restricted common shares as incentive compensation to two executives who joined the Company in the first quarter of 2021. |
12
Common Stock Warrants Outstanding – Following is a summary of warrants outstanding:
| # of Warrants | Exercise Price (each) | Expiration Date | Method of Exercise | |||||||||||
| Issued upon exchange of EHR Series C Preferred Stock (1) | 1,065,340 | $ | 0.352 | November 27, 2021 | Cash | |||||||||
| Issued upon exchange of EHR Series C Preferred Stock (1) | 7,244,316 | $ | 0.352 | November 27, 2021 | Cashless | |||||||||
| Issued in February 2020 with common stock units (2) | 250,000 | $ | 0.400 | March 1, 2022 | Cash | |||||||||
| Issued in December 2020 with Series B preferred units (1) | 5,500,000 | $ | 0.352 | December 30, 2022 | Cash | |||||||||
| Issued in December 2020 with subordinated note to investor (1) | 500,000 | $ | 0.352 | December 30, 2022 | Cash | |||||||||
| Issued in Q1 2021 with common stock units (1) | 1,600,000 | $ | 0.500 | Jan-Feb, 2023 | Cash | |||||||||
| Total warrants outstanding at December 31, 2020 | 16,159,656 | |||||||||||||
| # of Warrants | Exercise Price (each) | Expiration Date | Method of Exercise | |||||||||
Issued upon exchange of EHR Series C Preferred Stock (1) | 1,065,340 | $ | 0.352 | November 27, 2021 | Cash | |||||||
| Issued upon exchange of EHR Series C Preferred Stock (1) | 7,244,316 | $ | 0.352 | November 27, 2021 | Cashless | |||||||
| Issued in February 2020 with common stock units (2) | 250,000 | $ | 0.400 | March 1, 2022 | Cash | |||||||
| Issued in December 2020 with Series B preferred units (1) | 5,500,000 | $ | 0.352 | December 30, 2022 | Cash | |||||||
| Issued in December 2020 with subordinated note to investor (1) | 500,000 | $ | 0.352 | December 30, 2022 | Cash | |||||||
| Issued in Q1 2021 with common stock units (1) | 1,600,000 | $ | 0.500 | Jan-Feb, 2023 | Cash | |||||||
| Total warrants outstanding at September 30, 2021 | 16,159,656 | |||||||||||
| (1) | May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock. |
| (2) | Contains certain anti-dilution provisions requiring a downward adjustment to the exercise price of the warrant if dilutive instruments are issued at prices less than the warrant exercise price. |
Following is a summary of outstanding stock warrants activity for the periods presented:
| Warrants as of January 1, 2020 | 14,488,632 | |||
| Issued | 250,000 | |||
| Warrants as of | 14,738,632 | |||
| Warrants as of January 1, 2021 | 22,988,632 | |||
| Issued | 1,600,000 | |||
| Exercised | (8,428,976 | ) | ||
| Warrants as of | 16,159,656 |
9. Stock-Based Compensation
We award restricted stock or stock options as incentive compensation to employees. Generally, these awards include vesting periods of up to three years from the date of grant.
The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. The number of shares of common stock available for issuance under the 2021 Plan constituted approximately 13.1% of the Company’s fully diluted common shares outstanding as of the date of Board approval, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance thereunder shall automatically increase to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.
In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $158,500 as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $42,250$38,750 and $119,750 for the three and nine months ended March 31, 2021.September 30, 2021, respectively. As of March 31,September 30, 2021, there was $116,250$38,750 of total unrecognized compensation cost related to unvested awards to be recognized over a weighted-average period of ninethree months.
10. Income Taxes
Income tax provisions for interim quarterly periods are generally based on an estimated annual effective income tax rate calculated separately from the effect of significant, infrequent or unusual items related specifically to interim periods. An income tax benefit for the three months ended March 31, 2021 or 2020 was not recognized because tax losses incurred were fully offset by a valuation allowance against deferred tax assets. There were no uncertain tax positions as of March 31, 2021.
13
11. Supplemental Cash Flow Information
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Cash paid for interest | $ | 31,446 | $ | - | ||||
| Cash paid for taxes | - | - | ||||||
| Noncash investing and financing activities: | ||||||||
| Acquisition of certain assets of Halcyon Thruput, LLC | ||||||||
| - issuance of common shares | 2,500,000 | - | ||||||
| - issuance of subordinated note | 850,000 | - | ||||||
| - assumption of Halcyon bank note | 995,614 | - | ||||||
| Series B preferred stock dividend payable | 20,250 | - | ||||||
| Issuance of common stock units previously subscribed | 50,000 | - | ||||||
| Issuances of common shares for exchange or conversion of debt | 2,160,269 | - | ||||||
12. Earnings (Loss) per Share
The following is the computation of earnings (loss) per basic and diluted share:
| For the three months ended March 31, | ||||||||
| 2021 | 2020 | |||||||
| Amounts attributable to Generation Hemp: | ||||||||
| Numerator | ||||||||
| Loss from continuing operations attributable to common stockholders | $ | (1,833,588 | ) | $ | (718,888 | ) | ||
| (Loss) income from discontinued operations | (3,294 | ) | 6,322 | |||||
| Less: preferred stock dividends | (20,250 | ) | - | |||||
| Net loss attributable to common stockholders | $ | (1,857,132 | ) | $ | (712,566 | ) | ||
| Denominator | ||||||||
| Weighted average shares used to compute basic EPS | 26,691,992 | 17,242,955 | ||||||
| Dilutive effect of preferred stock | 79,322,376 | 75,947,376 | ||||||
| Dilutive effect of common stock warrants | 9,881,349 | 3,325,039 | ||||||
| Weighted average shares used to compute diluted EPS | 115,895,717 | 96,515,370 | ||||||
| Earnings (loss) per share: | ||||||||
| Loss from continuing operations | ||||||||
| Basic | $ | (0.07 | ) | $ | (0.04 | ) | ||
| Diluted | $ | (0.07 | ) | $ | (0.04 | ) | ||
| (Loss) income from discontinued operations | ||||||||
| Basic | $ | (0.00 | ) | $ | 0.00 | |||
| Diluted | $ | (0.00 | ) | $ | 0.00 | |||
| Earnings (loss) per share | ||||||||
| Basic | $ | (0.07 | ) | $ | (0.04 | ) | ||
| Diluted | $ | (0.07 | ) | $ | (0.04 | ) | ||
The computation of diluted earnings per common share excludes the assumed conversion of the Series A and Series B Preferred Stock and exercise of common stock warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding warrants was calculated using the treasury stock method.
14
13. Subsequent Events
On April 6, 2021, the Company announced that Chad Burkhardt has joined the Company as its Vice President and General Counsel, effective April 1, 2021. In addition to his annual salary, the Company agreed to make a future grant to Mr. Burkhardt of $750,000 worth of options for the purchase of our common stock at an exercise price equal to the fair market value of the Company’s common stock on the date of grant. Such options will vest annually in equal installments over a three yearthree-year period from his date of hire.
On April 20,10. Income Taxes
Income tax provisions for interim quarterly periods are generally based on an estimated annual effective income tax rate calculated separately from the effect of significant, infrequent or unusual items related specifically to interim periods. An income tax benefit for the three and nine months ended September 30, 2021 or 2020 was not recognized because tax losses incurred were fully offset by a valuation allowance against deferred tax assets. There were no uncertain tax positions as of September 30, 2021.
11. Supplemental Cash Flow Information
| For the nine months ended September 30, | ||||||||
| 2021 | 2020 | |||||||
| Cash paid for interest | $ | 127,812 | $ | - | ||||
| Cash paid for taxes | - | - | ||||||
| Noncash investing and financing activities: | ||||||||
| Acquisition of certain assets of Halcyon Thruput, LLC | ||||||||
| - issuance of common shares | 2,500,000 | - | ||||||
| - issuance of subordinated note | 850,000 | - | ||||||
| - assumption of Halcyon bank note | 995,614 | - | ||||||
| Series B preferred stock dividend payable | 39,137 | - | ||||||
| Issuance of common stock units previously subscribed | 50,000 | - | ||||||
| Issuances of common shares for exchange or conversion of debt | 2,160,269 | - | ||||||
12. Earnings (Loss) per Share
The following is the computation of earnings (loss) per basic and diluted share:
| For the three months ended September 30, | For the nine months ended September 30, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Amounts attributable to Generation Hemp: | ||||||||||||||||
| Numerator | ||||||||||||||||
| Loss from continuing operations attributable to common stockholders | $ | (1,376,030 | ) | $ | (171,367 | ) | $ | (4,356,315 | ) | $ | (1,146,592 | ) | ||||
| Loss from discontinued operations | (1,528 | ) | (7,489 | ) | (10,639 | ) | (5,115 | ) | ||||||||
| Less: preferred stock dividends | (16,125 | ) | - | (56,625 | ) | - | ||||||||||
| Net loss attributable to common stockholders | $ | (1,393,683 | ) | $ | (178,856 | ) | $ | (4,423,579 | ) | $ | (1,151,707 | ) | ||||
| Denominator | ||||||||||||||||
| Weighted average shares used to compute basic EPS | 54,109,797 | 17,380,317 | 38,693,679 | 17,500,308 | ||||||||||||
| Dilutive effect of convertible note | - | - | - | - | ||||||||||||
| Dilutive effect of preferred stock | 59,913,657 | 75,947,376 | 72,641,084 | 75,947,376 | ||||||||||||
| Dilutive effect of common stock warrants | 9,042,419 | - | 11,126,327 | - | ||||||||||||
| Weighted average shares used to compute diluted EPS | 123,065,873 | 93,327,693 | 122,461,090 | 93,447,684 | ||||||||||||
| Earnings (loss) per share: | ||||||||||||||||
| Loss from continuing operations | ||||||||||||||||
| Basic | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Diluted | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| (Loss) income from discontinued operations | ||||||||||||||||
| Basic | $ | - | $ | - | $ | - | $ | - | ||||||||
| Diluted | $ | - | $ | - | $ | - | $ | - | ||||||||
| Earnings (loss) per share | ||||||||||||||||
| Basic | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
| Diluted | $ | (0.03 | ) | $ | (0.01 | ) | $ | (0.11 | ) | $ | (0.07 | ) | ||||
The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding warrants was calculated using the treasury stock method.
13. Subsequent Events
In October 2021, the Company’s PPP LoanCompany issued 416,667 common stock units to an accredited investor for total proceeds of $250,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of one share of common stock for $0.60 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance.
As disclosed in Note 5 above, (i) we amended the subordinated note to our CEO in the amount of $25,200 was forgiven.$490,000 to a new maturity date of January 31, 2022, (ii) we amended the secured promissory note to Coventry Asset Management, LTD. to a new maturity date of January 31, 2022 with an earlier maturity date of December 31, 2021 in the event of a new equity capital raise is completed and granted the holder a limited option to convert part of the principal to common stock and (iii) we amended the subordinated promissory note with an investor to a new maturity date of March 31, 2022 with an earlier maturity date of December 31, 2021 in the event of a new equity capital raise is completed.
In October 2021, our CEO made advances totaling $15,000 to the Company. The existing convertible promissory note was amended and restated to a new balance of $635,000. The interest rate of 10% per annum and maturity date of January 1, 2022 were unchanged.
As disclosed in Note 6 above, the mortgage payable was amended to a new maturity date of January 15, 2022.
* * * * *
15
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in our Annual Report on Form 10-K (“Annual Report”) for the year ended December 31, 2020 filed with the Securities and Exchange Commission (“SEC”), as well as the financial statements and related notes appearing therein and elsewhere in this Quarterly Report. The following discussion contains forward-looking statements that reflect our future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside our control. We caution you that our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences are discussed elsewhere in this Quarterly Report, particularly in the “Cautionary Note Regarding Forward-Looking Statements” and in our Annual Report under the heading “Item 1A. Risk Factors,” all of which are difficult to predict. In light of these risks, uncertainties and assumptions, the forward-looking events discussed may not occur. We do not undertake any obligation to publicly update any forward-looking statements except as otherwise required by applicable law.
Overview
We are a holding company active within the “hemp” space. We were incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated on July 28, 2008 in the State of Colorado. On November 27, 2019, we purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger (the “Transaction”). Upon closing of the Transaction, we changed our name to Generation Hemp, Inc.
There is limited historical financial information about our Company upon which to base an evaluation of our future performance. We cannot guarantee that we will be successful in the hemp business. We are subject to the risks associated with the regulatory environment in the industry in which we operate. In addition, we are subject to risks inherent in a small company, including limited capital resources, delays and cost overruns due to price and cost increases. There is no assurance that future financing will be available to our Company on acceptable terms. Additional equity financing could result in dilution to existing shareholders.
On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. TheIn August 2021, the Company planslaunched its animal bedding consumer goods product line made from the hemp hurd byproduct that is produced from its hemp processing operations.
In 2020, Halcyon had revenues of $3.0 million for the processing of approximately 8.5 million pounds of hemp biomass. With additional contracts executed in 2021, we expect to significantly expand its business lines to include post-processingprocess at least 10 million pounds during the remainder of biomass for use in a number2021 and the first six months of new products. This expansion will require certain new equipment be procured.2022.
We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to a hemp seed company.
As of March 31,September 30, 2021, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.
Liquidity – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its new strategy and execute its acquisition plans.
We are focused on executing ourIn the nine months ended September 30, 2021, the Company used $2.7 million of cash for its operating strategy now thatactivities. At September 30, 2021, the Halcyon acquisition has been completed. Management expectsCompany’s current liabilities, including financing obligations due within one year, totaled $4.7 million as compared with its current assets of $276 thousand. Cash payments under several financing obligations were initially due in September and October of 2021. These were subsequently amended to renew contracts with new and existing Halcyon customers for the 2021 harvest. Expansion of our business lines is also expectedextend these payments by one to result in growth in revenues.six months.
The Company will continue to pursue additional fundingcapital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Impact of COVID-19 Pandemic on Our Business – Our business, results of operations and financial condition have been adversely affected by the COVID-19 pandemic, beginning in mid-March 2020. The COVID-19 pandemic and measures taken to contain it have subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.
16
Results of Operations
Three Months Ended March 31,September 30, 2021 Compared to Three Months Ended March 31,September 30, 2020
The net loss for the three months ended March 31,September 30, 2021 was $1.8$1.4 million as compared with a net loss of $743$179 thousand for the same period of 2020. We completed the acquisition of Halcyon in January 2021. The first six monthspart of each calendar year is typically a slower period for midstream operations within the hemp industry until the annual harvest begins in late-summer. We are presently pursuinghad $487 thousand of revenue for post-harvest and midstream services contracts with customersin the three months ended September 30, 2021. Cost of revenue was $280 thousand during this same period resulting in a gross margin of 43%. The net loss for the three months ended September 30, 2021 harvest season including larger volume customers that could require year-round processing.includes $316 thousand for depreciation and amortization as compared with $16 thousand in the 2020 period due to the Halcyon acquisition. General and administrative expenses were higher by approximately $1.0 million because of corporate staffing additions made this year and higher legal and professional fees incurred.
The Company reports its oil & gas activities as discontinued operations. Loss from discontinued operations was $4$2 thousand for the three months ended March 31,September 30, 2021 as compared with incomea loss of $7$8 thousand in the 2020 period. Results of operations for the Company’s remaining oil & gas activities have been significantly reduced due to downturns in oil & gas pricing and production and disposals of property interests.
Revenue. Revenue from continuing operations for the firstthird quarter of 2021 includes limited post-harvesttotaled $502 thousand as compared with $22 thousand for the same period of 2020. Post-harvest and midstream services revenuecommenced regular operations for new and renewed customer contracts executed in the third quarter of $45 thousand since completion of the Halcyon acquisition due to seasonality.2021. Rental revenue totaling $22totaled $15 thousand was unchanged in the 2021 andperiod as compared with $22 thousand in the 2020 periods.period. The Company leases itslease of the Company’s Denver warehouse underwas recently extended with a leasenew tenant to August 1, 2023 for $7.5 thousand per month expiring June 30, 2021.month.
Cost of Revenue. Cost of revenue for the firstthird quarter of 2021 was $158$280 thousand and consisted of direct labor, supplies and overhead for the Company'sCompany’s post-harvest and midstream services operations which commenced withoperations. The gross margin on revenue was 43% for the Halcyon acquisition.third quarter of 2021.
Merger and Acquisition Costs. We incurred $11$7 thousand of costs for evaluating acquisition opportunities during the three months ended March 31, 2021 and $86 thousand in such expenses in the comparable 2020 period as a result of the Halcyon acquisition.September 30, 2020. The amount of future expenses of this type that we incur will depend upon our future acquisition activities.
General and Administrative Expense. General and administrative expenses totaled $1.1 million for the three months ended March 31,September 30, 2021 as compared with $570$109 thousand in 2020 period. The increase in general and administrative expense in the 2021 period is principally due to bonus compensation totaling $600 thousand paid to our CEO for successful completion of the Halcyon acquisitioncorporate staffing additions made this year and achievement of strategic goals for the Company partially offset by lowerhigher legal and professional fees incurred. This special bonus was also givenIn the third quarter of 2021, the Company paid $189 thousand for legal fees and $33 thousand of interest in considerationsettlement of the minimal compensation paid to the CEO during calendar year 2020.arbitration with a law firm. General and administrative expense for the firstthird quarter of 2021 also includes $42$39 thousand of non-cash stock-based compensation expense.
Depreciation and Amortization. Depreciation and amortization expense totaled $350$316 thousand in the three months ended March 31,September 30, 2021 as compared with $23$16 thousand for the same period of 2020. The increase in the 2021 period is due to completion of the Halcyon acquisition including $245$201 thousand for amortization of acquired intangible assets. The allocation of the purchase price to the assets acquired in the Halcyon acquisition is preliminary. Final adjustments, including increases and decreases to depreciation and amortization resulting from the allocation of the purchase price to amortizable tangible and intangible assets, may be material.
Other Income/Expense. Total other expense was $252$156 thousand for the three months ended March 31,September 30, 2021 as compared with $93$67 thousand for the comparable 2020 period. The largest item of total other expense is interest expense which has increased due to having higher levels of indebtedness. Interest expense for the 2021 period includes $34 thousand of amortization of debt discounts totaling $163 thousand.and $33 thousand of interest for the arbitration settlement discussed above.
Loss from Discontinued Operations. In the three months ended September 30, 2020, we recognized a loss from discontinued operations of $8 thousand as compared with a loss of $2 thousand in the three months ended September 30, 2021. The major classes of line items constituting the loss on discontinued operations are presented in Item I, “Financial Statements – Note 4 – Discontinued Operations.” Until we fully dispose of our remaining oil & gas property interests, we expect lower future revenues and costs as production activities have declined substantially. We do not anticipate making future investment of growth capital into these properties.
Nine Months Ended September 30, 2021 Compared to Nine Months Ended September 30, 2020
The net loss for the nine months ended September 30, 2021 was $4.4 million as compared with a net loss of $1.2 million for the same period of 2020. The net loss for the nine months ended September 30, 2021 includes $1.0 million for depreciation and amortization as compared with $55 thousand in the 2020 period principally due to the Halcyon acquisition. Our remaining operating expenses were higher by approximately $2.3 million because of the Halcyon acquisition, other corporate staffing additions made this year, the payment of bonus compensation in the first quarter of 2021 and the arbitration settlement discussed above.
The Company reports its oil & gas activities as discontinued operations. Loss from discontinued operations was $11 thousand for the nine months ended September 30, 2021 as compared with a loss of $5 thousand in the 2020 period.
Revenue. Revenue from continuing operations for the first nine months of 2021 includes post-harvest and midstream services revenue of $535 thousand. Post-harvest and midstream services commenced regular operations for new and renewed customer contracts executed in the third quarter of 2021. These revenues are typically limited due during the first half of each year until harvest. Rental revenue was $60 thousand in the 2021 as compared with $68 thousand in the 2020 period. The lease of the Company’s Denver warehouse was recently extended with a new tenant to August 1, 2023 for $7.5 thousand per month.
Cost of Revenue. Cost of revenue for the first nine months of 2021 was $550 thousand and consisted of direct labor, supplies and overhead for the Company’s post-harvest and midstream services operations. We operated with limited staffing until harvest.
Merger and Acquisition Costs. We incurred $16 thousand and $100 thousand of costs for evaluating acquisition opportunities during the nine months ended September 30, 2021 and 2020, respectively. These costs principally related to the Halcyon acquisition. The amount of future expenses of this type that we incur will depend upon our future acquisition activities.
General and Administrative Expense. General and administrative expenses totaled $2.8 million for the nine months ended September 30, 2021 as compared with $884 thousand in 2020 period. The increase in general and administrative expense in the 2021 period is principally due the Halcyon acquisition, other corporate staffing additions made this year and the payment of bonus compensation in the first quarter of 2021. Bonus compensation totaling $600 thousand was paid to our CEO for successful completion of the Halcyon acquisition. In the third quarter of 2021, the Company paid $189 thousand for legal fees and $33 thousand of interest in settlement of the arbitration with Jones & Keller, P.C. General and administrative expense for the 2021 period also includes $120 thousand of non-cash stock-based compensation expense.
Depreciation and Amortization. Depreciation and amortization expense totaled $1.0 million in the nine months ended September 30, 2021 as compared with $55 thousand for the same period of 2020. The increase in the 2021 period is due to completion of the Halcyon acquisition including $693 thousand for amortization of acquired intangible assets. The allocation of the purchase price to the assets acquired in the Halcyon acquisition is preliminary. Final adjustments, including increases and decreases to depreciation and amortization resulting from the allocation of the purchase price to amortizable tangible and intangible assets, may be material.
Other Income/Expense. Total other expense was $615 thousand for the nine months ended September 30, 2021 as compared with $220 thousand for the comparable 2020 period. The largest item of total other expense is interest expense which has increased due to having higher levels of indebtedness. Interest expense for the 2021 period includes $380 thousand of amortization of debt discounts and $33 thousand of interest for the arbitration settlement discussed above.
In the first quarter of 2021, we sold our investment in the common stock we held for total proceeds of $35 thousand. This publicly traded security was marked to market each balance sheet datefiscal quarter until its eventual sale.
We received notice from the SBA that the Company’s PPP Loan principal and interest thereon was fully forgiven on April 20, 2021. As such, we recognized forgiveness income of $25,424 in the second quarter of 2021.
IncomeLoss from Discontinued Operations. In the threenine months ended March 31,September 30, 2020, we recognized incomea loss from discontinued operations of $7$5 thousand as compared with a loss of $4$11 thousand in the threenine months ended March 31,September 30, 2021. The major classes of line items constituting the loss on discontinued operations is presented in Item I, “Financial Statements – Note 4 – Discontinued Operations.” Until we fully dispose of our remaining oil & gas property interests, we expect lower future revenues and costs as production activities have declined substantially. We do not anticipate making future investment of growth capital into these properties.
Liquidity and Capital Resources
Our primary source of cash from continuing operations includes post-harvest and midstream services and rental revenue. Our primary uses of cash include our operating costs, general and administrative expenses and merger and acquisition expenses.
17
Cash flow information from continuing operations for the first threenine months of 2021 was as follows:
| ● | Cash used in operating activities was |
| ● | Net cash used in investing activities totaled |
| ● | Net cash from financing activities totaled |
We had no cash flows from discontinued operations in the first threenine months of 2021.
Funding Requirements
We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future. We anticipate that our expenses may increase substantially as we grow our hemp business.
We expect that we will require additional capital to fund operations, including hiring additional employees, completing acquisitions and funding capital expenditures during the next twelve-month period.
Because of the numerous risks and uncertainties associated with the development and commercialization of our business, we are unable to estimate the amounts of increased capital outlays and operating expenses. Our future capital requirements will depend on many factors, including:
| ● | our success in identifying and making acquisitions of profitable operations; |
| ● | our ability to negotiate operating contracts with growers and others within the hemp industry on favorable terms, if at all; |
| ● | deriving revenue from our assets and operations; and |
| ● | the cost of such operations and costs of being a public company. |
Until such time, if ever, as we can generate substantial revenues, we expect to finance our cash needs through a combination of equity offerings and debt financings. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common shareholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our growth plans and future commercialization efforts.
Indebtedness
The Company’s indebtedness at March 31,September 30, 2021 is presented in Item I, “Financial Statements – Note 5 – Notes Payable – Related Parties” and in Item I, “Financial Statements—Note 6—Other Indebtedness.”
Off-Balance Sheet Arrangements
As of March 31,September 30, 2021, we had no material off-balance sheet arrangements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Quantitative and qualitative disclosures about market risk are included in Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” of our Annual Report.
18
Item 4. Controls and Procedures
Disclosure Controls and Procedures
As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure, and is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report, at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities and migrating processes.
There have been no changes in our internal control over financial reporting during the quarter ended March 31,September 30, 2021 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
19
PART II. OTHER INFORMATION
Due to the nature of our business, we may become, from time to time, involved in routine litigation or subject to disputes or claims related to our business activities. While the outcome of these proceedings cannot be predicted with certainty, in the opinion of our management, there are no pending litigation, disputes or claims against us which, if decided adversely, individually or in the aggregate, will have a material adverse effect on our financial condition, cash flows or results of operations. For a description of our legal proceedings, see Item I, “Financial Statements – Note 7 – Commitments and Contingencies” in the Condensed Consolidated Financial Statements included in Part I of this Quarterly Report.
In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors and other cautionary statements described under the heading “Item 1A. Risk Factors” included in our Annual Report and the risk factors and other cautionary statements contained in our other SEC filings, which could materially affect our businesses, financial condition or future results.
Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes in our risk factors from those described in our Annual Report.
Item 4. Mine Safety Disclosures
No response required.
No response required.
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Schema Document | |
| 101.CAL | Inline XBRL Calculation Linkbase Document | |
| 101.DEF | Inline XBRL Definition Linkbase Document | |
| 101.LAB | Inline XBRL Label Linkbase Document | |
| 101.PRE | Inline XBRL Presentation Linkbase Document | |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| * | Exhibit filed herewith. |
| ** | Furnished herewith. Pursuant to SEC Release No. 33-8212, this certification will be treated as “accompanying” this Quarterly Report on Form 10-Q and not “filed” as part of such report for purposes of Section 18 of the Exchange Act or otherwise subject to the liability under Section 18 of the Exchange Act, and this certification will not be deemed to be incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference. |
20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| GENERATION HEMP, INC. | ||
| By: | Gary C. Evans | |
| Gary C. Evans | ||
| Chairman and Chief Executive Officer | ||
21
23